CVS/Caremark Corp

CVS Caremark Corporation (NYSE: CVS) is an integrated pharmacy services provider, combining a United States pharmaceutical services company with a U.S. pharmacy chain. CVS Caremark provides pharmacy services through its over 7,000 CVS/pharmacy and Longs Drugs stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. CVS Caremark Corporation is chartered in Delaware, and is headquartered in Woonsocket, Rhode Island, where its pharmacy business is also headquartered. The pharmacy services business is headquartered in Nashville, Tennessee. The company was #18 in the 2010 Fortune 500 list of the largest companies in the U.S., and is the largest company that has operations solely in the United States.

Source: Wikipedia

Campaign Finance

Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

Latest FEC Data

covers through committee's June 30, 2012 filing.
Download all contributions to CVS/Caremark Corp

  • Summary

    overview of the committee's finances
    Total Raised:
    $394,438
    Total Spent:
    $391,323
    Cash on Hand:
    $64,454
    Debts:
    $0

Standardized Donation Information

covers through 2011. may lag behind FEC section above, as donors and industries are identified by hand.

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars. "Other" includes 3rd parties and organizations without official party affiliation.

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for CVS/Caremark Corp Sources: OpenSecrets.org FollowTheMoney.org

Lobbying

$6,754,321 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of CVS/Caremark Corp

View all lobbying data for CVS/Caremark Corp Sources: OpenSecrets.org

Regulations

11 Mentions; 3 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "CVS/Caremark Corp" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 2 FAA Notice of Proposed Modification to the June 1, 2006 MOA FAA/Subscriber Memorandum of Agreement for ASDI/NASSI Industry Access and Request for Comments 2011
    • Toggle 1 FDA Draft Guidance for Industry on Medication Guide Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies (REMS); Availability 2011
    • Toggle 1 HHS HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 2 FAA Notice of Proposed Modification to the June 1, 2006 MOA FAA/Subscriber Memorandum of Agreement for ASDI/NASSI Industry Access and Request for Comments 2011
    • Toggle 2 HHS HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act 2011
    • Toggle 1 ITC Investigations: Certain Vaginal Ring Birth Control Devices 2011
    • Toggle 1 DHS Reducing Regulatory Burden; Retrospective Review under Executive Order 13563 2011
    • Toggle 1 CMS Medicare Program: Availability of Medicare Data for Performance Measurement 2011
    • Toggle 1 CMS Medicare Program: Solicitation of Comments Regarding Development of a Recovery Audit Contractor Program for the Medicare Part C and D Programs 2011
    • Toggle 1 CMS Standardized Pharmacy Notice: Your Prescription Cannot be Filled (f/k/a Medicare Prescription Drug Coverage and Your Rights) (CMS-10147) 2011
    • Toggle 1 FDA Draft Guidance for Industry on Medication Guide Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies (REMS); Availability 2011
    • Toggle 1 ITC Receipt of Complaint: Solicitation of Comments Relating to the Public Interest 2011
    • Toggle 1 CMS Medication Therapy Management Program Improvements—Standardized Format. (CMS-10396) 2011